Is Biolase Stock a good buy in 2023, according to Wall Street analysts?
The consensus among 1 Wall Street analyst covering (NASDAQ: BIOL) stock is to Strong Buy BIOL stock.
Out of 1 analyst, 1 (100%) are recommending BIOL as a Strong Buy, 0 (0%) are recommending BIOL as a Buy, 0 (0%) are recommending BIOL as a Hold, 0 (0%) are recommending BIOL as a Sell, and 0 (0%) are recommending BIOL as a Strong Sell.
According to 1 Wall Street analyst that have issued a 1 year BIOL price target, the average BIOL price target is $1.50, with the highest BIOL stock price forecast at $1.50 and the lowest BIOL stock price forecast at $1.50.
The Wall Street analyst predicted that Biolase's share price could reach $1.50 by Jan 20, 2024. The average Biolase stock price prediction forecasts a potential upside of 301.07% from the current BIOL share price of $0.37.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.